Finally, we show that miR-155 levels are in general high in NIAM-negative B-cell lymphomas and vice versa, supporting a role for miR-155 mediated downregulation of NIAM in the pathogenesis of B-cell lymphoma. Here, TBRG1 is linked to B-cell non-Hodgkin lymphoma.